Unlocking the power of Real-World Evidence to support clinical decision making
This course will focus on critically understanding the clinical utility of real-world evidence (RWE) in breast cancer research.
Using examples from cancer research, the course will address methods to maximize data quality, minimize bias in analyses, and improve the interpretation of results. In addition, this course provides tools for designing registries and prospective pragmatic trials, and discusses how RWE can support clinical and regulatory decision‑making. An opportunity to apply RWE rigorously in research.
Coordinators
This course is coordinated by Rodrigo Dientsmann (Vall d’Hebron Institute of Oncology) and Guillermo Villacampa (SOLTI, Vall d’Hebron Institute of Oncology).
Participants
Registrations to this course are free of charge. Please register using the form at the end of this page.
PROGRAM
24.02.2026
4 – 5 pm (UTC+01)
Critical analysis of real-world evidence in breast cancer: Detecting and minimizing potential biases
Rodrigo Dienstmann (Vall d’Hebron Institute of Oncology) y Guillermo Villacampa (SOLTI, Vall d’Hebron Institute of Oncology)
03.03.2026
4 – 5 pm (UTC+01)
Access and quality of clinico-genomic data in real-world databases: Experience from Foundation Medicine
Julia Quintanilha (Foundation Medicine, US)
10.03.2026
4 – 5 pm (UTC+01)
Design and execution of prospective registry-based studies and pragmatic trials
Antonios Valachis (Örebro University Hospital, Sweden)
17.03.2026
4 – 5 pm (UTC+01)
Creation of oncology registries: clinical value, epidemiologic data, and long-term feasibility
Andri Papakonstantinou (Karolinska University Hospital, Sweden)
24.03.2026
4 – 5 pm (UTC+01)
Value, utility and requirements of real-world evidence to support regulatory and clinical decision making
Asieh Golozar (Oncology Working Group at OHDSI)
Esto es una iniciativa apoyada por Pfizer dentro de su programa de becas a iniciativas independientes de investigación y formación continuada. Este programa de becas persigue la total independencia de la iniciativa, sus contenidos o acciones relacionadas
